德科立(688205) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was ¥187,607,204.27, representing a year-on-year increase of 13.32%[5] - The net profit attributable to shareholders for the same period was ¥23,011,513.81, reflecting a growth of 5.36% compared to the previous year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥17,138,217.07, which is an increase of 7.13% year-on-year[5] - Total revenue for Q1 2024 reached ¥187,607,204.27, an increase of 13.0% compared to ¥165,554,014.36 in Q1 2023[20] - Operating profit for Q1 2024 was ¥25,406,335.58, up from ¥21,901,888.53 in Q1 2023, reflecting a growth of 15.5%[21] - Net profit for Q1 2024 amounted to ¥23,011,513.81, compared to ¥21,841,167.37 in Q1 2023, representing an increase of 5.4%[21] - The company reported a comprehensive income total of ¥22,487,332.94 for Q1 2024, compared to ¥21,800,466.16 in Q1 2023, an increase of 3.1%[22] - Basic earnings per share for Q1 2024 were ¥0.23, compared to ¥0.22 in Q1 2023, indicating a growth of 4.5%[22] Cash Flow - The net cash flow from operating activities reached ¥36,582,945.90, showing a significant increase of 1,067.86% compared to the same period last year[5] - In Q1 2024, the company reported cash inflows from operating activities of RMB 256,104,246.13, a significant increase of 93.4% compared to RMB 132,246,061.66 in Q1 2023[24] - The net cash flow from operating activities was RMB 36,582,945.90, recovering from a negative cash flow of RMB -3,779,773.84 in the same period last year[25] - Total cash outflows for operating activities reached RMB 219,521,300.23, an increase of 61.5% from RMB 136,025,835.50 in the same quarter last year[25] - The company’s cash and cash equivalents decreased by RMB 840,397,753.86 in Q1 2024, contrasting with an increase of RMB 53,378,016.86 in Q1 2023[25] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,499,072,495.92, a decrease of 2.36% from the end of the previous year[6] - Total assets decreased to ¥2,499,072,495.92 in Q1 2024 from ¥2,559,593,576.62 in Q1 2023, a decline of 2.4%[19] - Total liabilities decreased to ¥303,534,673.49 in Q1 2024 from ¥390,243,667.62 in Q1 2023, a reduction of 22.2%[19] - The company's equity increased to ¥2,195,537,822.43 in Q1 2024 from ¥2,169,349,909.00 in Q1 2023, reflecting a growth of 1.2%[19] Research and Development - Research and development expenses totaled ¥21,912,473.89, accounting for 11.68% of operating revenue, an increase of 0.65 percentage points[6] - Research and development expenses increased to ¥21,912,473.89 in Q1 2024, up from ¥18,263,253.81 in Q1 2023, marking a rise of 20.0%[21] Shareholder Information - The total number of common shareholders at the end of the reporting period was 7,311[10] - The largest shareholder, Wuxi Taikeling Science and Technology Investment Partnership, held 24.56% of the shares[10] - There are no changes in the top 10 shareholders or their participation in financing activities[12] Other Information - The company has not reported any significant new product developments or market expansions in this quarter[13] - The company has not provided any specific future outlook or performance guidance in this report[13] - The company reported non-recurring gains of ¥5,873,296.74 after tax[8]